DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Vintafolide is an investigational drug.
There have been 9 clinical trials for Vintafolide. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Lung Neoplasms, Ovarian Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Endocyte and [disabled in preview].
Recent Clinical Trials for Vintafolide
|Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)||Endocyte||Phase 2|
|A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)||Endocyte||Phase 1|
|A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)||Endocyte||Phase 1|